Dr. Gregg Cappon is a pharmacological toxicologist with more than 25 years of experience in the pharmaceutical industry. His expertise focuses on nonclinical safety assessment and drug development, with an emphasis on reproductive toxicology and pediatric drug development. He has managed organizations of up to 34 scientists in designing and conducting studies to support drug development candidates, internal and external study conduct, preparation of regulatory submission, and responding to regulatory queries. In addition to management responsibilities, he has experience as a drug development project team representative, affording him broad knowledge of drug development and regulatory strategies, including vaccines, nonalcoholic steatohepatitis (NASH), dermatology, pain, osteoporosis, and various metabolic and central nervous system (CNS) conditions. Provided project team support at all stages of the drug development process, from discovery research, to investigational new drug (IND) submission, through early and late clinical development, to marketing authorization.